KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AbCellera Biologics (ABCL) Shares Outstanding (Weighted Average) (2020 - 2026)

AbCellera Biologics filings provide 7 years of Shares Outstanding (Weighted Average) readings, the most recent being $303.1 million for Q1 2026.

  • Quarterly Shares Outstanding (Weighted Average) rose 1.81% to $303.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $303.1 million through Mar 2026, up 1.81% year-over-year, with the annual reading at $151.3 million for FY2019, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) hit $303.1 million in Q1 2026 for AbCellera Biologics, up from $298.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $303.1 million in Q1 2026 and bottomed at $283.9 million in Q1 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $292.1 million, with a median of $292.7 million recorded in 2024.
  • The largest annual shift saw Shares Outstanding (Weighted Average) rose 5.26% in 2022 before it rose 1.36% in 2023.
  • AbCellera Biologics' Shares Outstanding (Weighted Average) stood at $285.3 million in 2022, then increased by 1.46% to $289.5 million in 2023, then increased by 1.53% to $293.9 million in 2024, then grew by 1.51% to $298.4 million in 2025, then increased by 1.58% to $303.1 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Shares Outstanding (Weighted Average) are $303.1 million (Q1 2026), $298.4 million (Q3 2025), and $298.5 million (Q2 2025).